<?xml version="1.0" encoding="UTF-8"?>
<ref id="B3">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aminizadeh</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Alavianm</surname>
    <given-names>S. M.</given-names>
   </name>
   <name>
    <surname>Akbari Sarm</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ebrahimi Daryani</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Behnava</surname>
    <given-names>B.</given-names>
   </name>
  </person-group> (
  <year>2016</year>). 
  <article-title>Safety and efficacy of adding ribavirin to interferon or peginterferon in treatment of hepatitis C infection in patients with thalassemia: a systematic review on randomized controlled trials</article-title>. 
  <source>Hepat. Mon</source>. 
  <volume>6</volume>:
  <fpage>e28537</fpage>. 
  <pub-id pub-id-type="doi">10.5812/hepatmon.28537</pub-id>
  <?supplied-pmid 27226796?>
  <pub-id pub-id-type="pmid">27226796</pub-id>
 </mixed-citation>
</ref>
